Sanofi (TSX:SNY)
22.36
0.00 (0.00%)
Nov 12, 2026, 3:57 PM EST
Sanofi Employees
Sanofi had 74,846 employees as of December 31, 2025. The number of employees decreased by 8,032 or 9.69% compared to the previous year.
Employees
74,846
Change (1Y)
-8,032
Growth (1Y)
-9.69%
Revenue / Employee
1.10M CAD
Profits / Employee
89.99K CAD
Market Cap
165.05B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 74,846 | -8,032 | -9.69% |
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Vitalhub | 700 |
Sanofi News
- 3 hours ago - DNA drug developer Seawolf launches with $100 million funding, Sanofi deal - Reuters
- 23 hours ago - Rugby centre Henry Slade and his father look back: ‘I’d seen my dad live with diabetes, so my diagnosis wasn’t as upsetting as it might have been’ - The Guardian
- 2 days ago - Sanofi price target raised to EUR 93 from EUR 78 at Citi - TheFly
- 4 days ago - The world's most sophisticated drug companies are putting billions into vaccines — despite the political environment - Market Watch
- 5 days ago - FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications - The Guardian
- 7 days ago - Sanofi upgraded to Outperform from Neutral at BNP Paribas - TheFly
- 10 days ago - Novavax Q3 Earnings Call Highlights - Nasdaq
- 10 days ago - Novavax (NVAX) Q3 2026 Earnings Call Transcript - The Motley Fool